Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder.
Saved in:
| Title: | Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder. |
|---|---|
| Authors: | Liu Q; Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China., Xue Y; Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China., Guo J; Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China., Tao L; Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China., Zhu Y; Department of Orthopedics, The First Hospital of China Medical University, Shenyang, China. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Jan 16; Vol. 15, pp. 1512398. Date of Electronic Publication: 2025 Jan 16 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2024.1512398 |
